Data for: New-Onset Diabetes After Androgen-Deprivation Therapy For Prostate Cancer: A Nationwide Propensity Score-Matched Four-Year Longitudinal Cohort Study

Published: 14 June 2018| Version 1 | DOI: 10.17632/693gg6gkd2.1
Ching Chia Li, Yii-Her Chou, Hsin-Chih Yeh, Wen-Jeng Wu, Yu-Han Chang, Shiao-Jin Guu, Jhen Hao Jhan


There is a strong link between long-term ADT and diabetes in prostate cancer patients. The association was particularly striking in the subgroup of patients receiving complete androgen blockade. Most patients with prostate cancer die of conditions other than their primary cancer, including complications of ADT. Physicians should discuss with the patient in detail and inform the patient of the possible risk of ADT before starting treatment.



Drug Therapy for Prostate Cancer